Featured Research

from universities, journals, and other organizations

Artificial antibodies hold biomedical promise

Date:
May 20, 2010
Source:
Arizona State University
Summary:
Researchers have developed a much faster and simpler way of making synthetic antibodies, by carrying out the usual steps in reverse. They have developed a technique for constructing peptide sequences, then linking them together to form a synthetic antibody, or synbody, that can bind with one or more protein molecules contained in the vast repository of human proteins -- the proteome.

Researchers have developed a synthetic antibody, or synbody, capable of binding a critical protein believed to play a role in aging, obesity, and cancer.
Credit: Courtesy of ASU Biodesign Institute

Antibodies are the immune system's warriors. Their role is to pinpoint disease pathogens, attaching to them and neutralizing their effects. Though antibodies are of great value for biomedical research, the process of creating them has been time-consuming and tedious. Researchers at the Biodesign Institute at Arizona State University have developed a much faster and simpler way of making synthetic antibodies, by carrying out the usual steps in reverse.

Stephen Albert Johnston and Chris Diehnelt of Biodesign's Center for Innovations in Medicine at Arizona State University, along with their colleagues, have developed a technique for constructing amino acid sequences, then linking them together to form a synthetic antibody, or synbody, that can bind with one or more protein molecules contained in the vast repository of human proteins -- the proteome.

The group has developed a high affinity synbody capable of binding with AKT-1, a critical protein believed to play a role in aging, obesity, and cancer. In addition to the potential of synbodies to directly target proteins associated with disease-causing microbes, they also show great potential as a research tool and building block for novel diagnostics and treatments. The team's findings appear in the current issue of the journal PLoS ONE.

As Johnston notes, traditional antibodies are already in wide use for biological research, but the existing procedures for producing them are laborious and costly. "Traditional antibodies are made by taking the protein you want to bind," Johnston says, "and injecting it into an animal, which responds by making antibodies." These antibodies, or the cells that produce them, are then extracted.

Rather than beginning with a protein in order to produce an antibody, the new technique involves building an antibody first. "We turn the whole process on its head, making the antibody chemically, then finding out what it's an antibody to," Johnston says.

To accomplish this, a 20-unit random sequence of amino acids are joined together like beads on a necklace to form a peptide. By uniting two of these peptide chains, linked together by means of a chemical scaffold, a binding molecule or ligand is created, which can attach to a specific protein with high affinity. The resulting synbody may then be screened against a multitude of human proteins, to find its mate.

The strategy relies on the fact that the binding affinity of two such amino acid sequences is the product of their combined affinity, allowing two peptides with weak attraction to a given protein to be joined to produce a synbody with strong binding properties. Remarkably, the assemblage of both the individual peptides and the synbody are carried out randomly.

The raw material for the synbody comes from a library of 10,000 peptides, with each amino acid sequence randomly composed. As Johnston explains, "the randomness turned out to be the key to all of this, because a random sequence has more flexibility and degrees of freedom than life sequences do." Each resulting linear peptide chain is able to find 2 or 3 points of contact with virtually any protein. When two such peptides are combined to form a synbody, a high-affinity ligand is produced, displaying specificity for a given protein.

Currently, the only limiting technological consideration is the number of proteins that can be placed on an array slide and that capability, as Johnston notes, is rapidly improving. Another key advantage in the use of synbodies is that they remain stable over time, unlike their biological counterparts, making them far more suitable for diagnostic assays.

Exposing random synbodies to multiple proteins helps build a library of effective ligands over time. To create a synbody to a particular disease protein on the other hand, the protein is exposed to multiple peptides. Once two are identified that link to the protein, they may be combined into a disease-specific synbody -- an effective, though much slower process.

The ability to produce ligands to all 30,000 proteins in the human proteome would be a boon to science, offering the ability to study any protein in the body with fine-grained specificity and to develop a suite of new diagnostic tools. Proposals exist to complete such a daunting task by traditional means, at an estimated cost of $1 billion over the course of ten years.

"I'm too impatient," Johnston says. "And it's too much money." The synbody approach, in which a Lego-like peptide kit is used to produce high-affinity ligands offers a plausible route to addressing the problem by high throughput means at substantially lower cost.


Story Source:

The above story is based on materials provided by Arizona State University. The original article was written by Richard Harth, Biodesign Institute Science Writer. Note: Materials may be edited for content and length.


Journal Reference:

  1. Chris W. Diehnelt, Miti Shah, Nidhi Gupta, Paul E. Belcher, Matthew P. Greving, Phillip Stafford, Stephen Albert Johnston. Discovery of High-Affinity Protein Binding Ligands - Backwards. PLoS ONE, 2010; 5 (5): e10728 DOI: 10.1371/journal.pone.0010728

Cite This Page:

Arizona State University. "Artificial antibodies hold biomedical promise." ScienceDaily. ScienceDaily, 20 May 2010. <www.sciencedaily.com/releases/2010/05/100519173100.htm>.
Arizona State University. (2010, May 20). Artificial antibodies hold biomedical promise. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2010/05/100519173100.htm
Arizona State University. "Artificial antibodies hold biomedical promise." ScienceDaily. www.sciencedaily.com/releases/2010/05/100519173100.htm (accessed October 21, 2014).

Share This



More Plants & Animals News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

White Lion Cubs Born in Belgrade Zoo

White Lion Cubs Born in Belgrade Zoo

AFP (Oct. 20, 2014) Two white lion cubs, an extremely rare subspecies of the African lion, were recently born at Belgrade Zoo. They are being bottle fed by zoo keepers after they were rejected by their mother after birth. Duration: 00:42 Video provided by AFP
Powered by NewsLook.com
Traditional Farming Methods Gaining Ground in Mali

Traditional Farming Methods Gaining Ground in Mali

AFP (Oct. 20, 2014) He is leading a one man agricultural revolution in Mali - Oumar Diatabe uses traditional farming methods to get the most out of his land and is teaching others across the country how to do the same. Duration: 01:44 Video provided by AFP
Powered by NewsLook.com
Goliath Spider Will Give You Nightmares

Goliath Spider Will Give You Nightmares

Buzz60 (Oct. 20, 2014) An entomologist stumbled upon a South American Goliath Birdeater. With a name like that, you know it's a terrifying creepy crawler. Sean Dowling (@SeanDowlingTV) has the details. Video provided by Buzz60
Powered by NewsLook.com
Adorable Video of Baby Rhino and Lamb Friend Playing

Adorable Video of Baby Rhino and Lamb Friend Playing

Buzz60 (Oct. 20, 2014) Gertjie the Rhino and Lammie the Lamb are teaching the world about animal conservation and friendship. TC Newman (@PurpleTCNewman) has the adorable video! Video provided by Buzz60
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Plants & Animals

Earth & Climate

Fossils & Ruins

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins